GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Calithera Biosciences CALA · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 6 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Calithera Biosciences

Our reporting

We have not reported on Calithera Biosciences yet.

Next results

17 Nov 2026

Due on 17 Nov 2026. Analysts expect earnings of -5.52 a share on revenue of $480,000.

Past results

Reported against what analysts expected

30 Mar 202314 Nov 202215 Aug 202210 May 202231 Mar 20229 Nov 2021
Earnings per share-1.42-2.01-1.59-3.60-4.80-3.00
Forecast-1.49-1.93-2.65-3.40-5.60-4.60
Revenue—————$6.8m
Forecast$1.0m$8.5m$750,000——$9.1m

Key events

  1. 15 Jun 202220-to-1 reverse split
  2. 2 Oct 2014Listed
  3. 8 Apr 20025-to-1 reverse split

Calithera Biosciences in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.